FROM CONCEPT TO LAUNCH
Customized Programs For Precision Medicine
Health systems, academic medical centers and community hospitals are looking to develop life-changing precision medicine and population genomics programs. However, many institutions face uncertainty about how to begin, risking costly delays or failures because they lack a comprehensive and scalable plan with an efficient roadmap, dedicated resources and experienced partners.Learn moreChat with us
Start Building Your Program
Today's rapidly-changing healthcare landscape requires efficiency, agility and long-term foresight. We will work with you to design the path forward that is best for you.
Genome Medical’s detailed medically-actionable approach considers all facets of the genomics and/or precision medicine program that is optimized for scaling, sustainability and success with a quality patient experience throughout the entire genetic journey.
Our fully-customizable, comprehensive suite of advisory services is designed to meet and exceed your program’s needs.Request infoChat with us
What We Provide
Genome Medical provides an adaptable, step-wise, medically-actionable approach that considers all facets of the genomics and precision health program.
Our expert advisors help your organization:
- Adopt best practices that create alignment
- Anticipate and avoid common pain points that lead to delay or failure
- Move quickly through all phases of the program journey — from initial planning into long-term and beyond
Our methods enable and support partners, empowering and accelerating their ability to drive program success.
Strategic Design &
Supporting precision medicine programs:
planning, execution and getting started
End-to-end solutions for clinical care, from recruitment and education, patient assessment, and test selection, to provider support, return of results and clinical care navigation
Value & Outcome Assessment
Structured outcomes assessment and process evaluation
From Concept to Launch
True End-to-End Solutions, Designed to Fit Your Needs
The road is rarely linear. We analyze and break down the key steps and help you create quantitative and concrete metrics to measure program success.
We learn about your plans and goals. What do you want to achieve? For which patients? And at what scale?
EMPOWER AND ACCELERATE
We explore your current capabilities and needs in order to leverage your strengths and provide support to extend your workforce.
We help customize the program that's built for you: research, clinical or both? Population-wide screening, indication-based testing or both?
We support your engagement and recruitment of patients and participants: starting with education materials and consenting, all the way from enrollment to return of results.
We guide your design of efficient workflows to engage and educate primary care physicians -- while not adding to their workload.
We explore options and help you select the tests that fit your program's goals. Whether it's a few genes or the whole genome, we help you get started with no delays.
Whether for hundreds of hundreds of thousands of patients, we can support your program with ready access to comprehensive genetic services: return of results, genetic counseling, physician support and clinical care plans.
Meet Our Experts
Our professionals guide your precision medicine program towards success and reaching its full potential.
Hunt Willard, PhD
Chief Scientific Officer and Senior Vice President of Medical Affairs
Hunt has deep experience in genetics and genomics leadership in academia, health care and industry, building teams that span research, education and clinical care. Prior to joining Genome Medical, he was most recently director and principal of National Precision Health at Geisinger Health in Maryland and Pennsylvania, with a focus on design and implementation of large-scale clinical and research programs in genomics and population screening. He is the author or co-author of more than 350 scientific publications, co-editor of the Genomic and Precision Medicine book series and a longtime co-author of the textbook Genetics in Medicine. A former president of the American Society of Human Genetics, he is an elected member of the National Academy of Medicine and the National Academy of Sciences.
Erica Ramos, MS, CGC
Vice President of Population Genomics
Erica is the vice president of population genomics at Genome Medical. She is responsible for developing the strategy, value proposition and overall approach to population-scale health initiatives utilizing genetics and genomics and is passionate about establishing genomics as a resource for life-long care and integrating broad-based screening approaches with indication-based diagnostic services. In her previous role as director of clinical and product development at Geisinger National Precision Health, she and her team developed and integrated scalable, efficient and innovative clinical programs and products to accelerate the responsible adoption and integration of genomics into preventive care and population health. Prior to joining Geisinger, Erica was an associate director of market development for Precision Health and Screening at Illumina and practiced as a clinical genetic counselor for 11 years. Erica is a nationally recognized leader in the genetic counseling community, serving as the 2018 president of the National Society of Genetic Counselors, the leading professional organization for genetic counselors, more than 4,000 members strong, and serving on the All of Us Research Program Advisory Panel. She is also an adjunct professor in the Genetic Counseling Department at Augustana University and shares her enthusiasm for genomics, genetic counseling and Wisconsin sports on Twitter at @ERamosSD.
Beth Denne, MS, CGC
Director of Education and Engagement
Beth is a board-certified and licensed genetic counselor, practicing since 2000. A leader in the genetic counseling community, Beth has served as president of the American Board of Genetic Counseling and on several committees for the National Society of Genetic Counselors. Prior to joining Genome Medical, Beth was the genetic counseling and education program leader for Geisinger National Precision Health. She previously served as director of genetic counseling services for Counsyl, Inc. During her seven years at Counsyl, she helped to develop and build the genetic counseling service, which incorporated new technologies and alternative service delivery models for telegenetic counseling into standard practice. Beth spent the first 12 years of her career at Johns Hopkins University Hospital as a Gyn/Ob faculty member in the Department of Maternal-Fetal Medicine.
Steven Bleyl, MD, PhD
Chief Medical Officer
Steve is Genome Medical’s chief medical officer. He is a board-certified medical geneticist and associate professor in medical genetics and pediatrics at the University of Utah. Previously, Steve directed the Clinical Genetics Institute for Intermountain Healthcare in Salt Lake City.
Robert Green, MD, MPH
Genome Medical Scientific Advisory Board Chairman
Robert is a professor of medicine at Harvard Medical School and directs the Genomes2People Research Program in translational genomics at Brigham and Women’s Hospital and Broad Institute. He conducts empirical research on the medical, behavioral and economic outcomes around the implementation of genomic medicine. Dr. Green is directing some of the first trials to explore sequencing in adults (the MedSeq Project) newborn infants (the BabySeq Project) and active-duty military personnel (the MilSeq Project).
Ready to learn more?
Let's Accelerate Your
Precision Medicine Program
Frequently Asked Questions
There are many approaches to building a precision medicine program. We provide organizations with strategic assessment of institutional goals, capabilities and needs so that the program you build will be the right fit for you.
We have worked with large multi-site and multi-specialty organizations, so we understand how this level of complexity can seem overwhelming. We will help you create strategies and provide support for the engagement and education of primary care providers and specialists alike.
We prioritize creating workflows that integrate into existing patient flows. We design provider and patient workflows to create value and ensure support.
There are many tests and testing platforms available in the marketplace. Which is best for our needs?
Health systems have important goals and tests and testing platforms are not one-size-fits-all. Our strategic advisors will lay out an array of options to help select the best test(s) for your studies and patients, from launch to scaling.
We’d like to simultaneously build a research program and impact clinical care. Is it possible to do both?
Absolutely. We will assess your priorities and capacities for both paths, and establish appropriate timelines and roadmaps to bridge these initiatives.
We will develop a customized plan to assess impact and demonstrate the value of your program to your institution.
The Latest from Our Experts
As the pandemic continues to challenge all of us, we’ve been giving a lot of thought to how health systems, hospitals and providers can guide patients back for genomic care. We have identified five key steps that we believe provide an excellent framework for ensuring that patients get the genomic care they need.
Precision medicine is a common term used in health care. But what does it mean? Learn more about what precision medicine is, what it is not and how this approach to medical care can be valuable to individuals, families and health systems when paired with clinical experts in genomic medicine.